Clinical Trials Browser

Invasive Bladder Cancer Stage IV × Interleukin-2 × Clear all

NCT02863913 2019-03-06

PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer

Phase 1 Withdrawn

Invasive Bladder Cancer Stage IV